"We propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill SARS-CoV-2 infected patients."

[0]https://academic.oup.com/cid/advance-article/doi/10.1093/cid...